Cargando…

Is 3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) a Clinically Relevant Uremic Toxin in Haemodialysis Patients?

3-Carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF) is a metabolite of furan fatty acid and a marker of fish oil intake. CMPF is described as a protein-bound uremic toxin and interacts with free oxygen radicals, which can induce cell damages. However, the clinical consequences of CMPF accumulation...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luce, Mathilde, Bouchara, Anais, Pastural, Myriam, Granjon, Samuel, Szelag, Jean Christophe, Laville, Maurice, Arkouche, Walid, Fouque, Denis, Soulage, Christophe O., Koppe, Laetitia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983261/ https://www.ncbi.nlm.nih.gov/pubmed/29783628 http://dx.doi.org/10.3390/toxins10050205

Ejemplares similares

The Role of Gut Microbiota and Diet on Uremic Retention Solutes Production in the Context of Chronic Kidney Disease
por: Koppe, Laetitia, et al.
Publicado: (2018)

Increased serum 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with glucose metabolism in Chinese pregnant women
por: Yi, J., et al.
Publicado: (2017)

Distal Colon Motor Dysfunction in Mice with Chronic Kidney Disease: Putative Role of Uremic Toxins
por: Hoibian, Elsa, et al.
Publicado: (2018)

Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population
por: Zhang, Shan, et al.
Publicado: (2017)

3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) induces cell death through ferroptosis and acts as a trigger of apoptosis in kidney cells
por: Park, Jung Sun, et al.
Publicado: (2023)

A surface-enhanced Raman scattering-based approach for rapid and highly sensitive quantitative analysis of 3-carboxy-4-methyl-5-propyl-2-furanpropionate and indole-3-acetic acid in saline, human serum and uremic serum of patients with chronic kidney disease
por: Saadati, Shaghayegh, et al.
Publicado: (2020)

Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
por: Barba, Christophe, et al.
Publicado: (2020)

Relative Change in NT-proBNP Level: An Important Risk Predictor of Cardiovascular Congestion in Haemodialysis Patients
por: Pastural-Thaunat, M., et al.
Publicado: (2012)

COVID-19 vaccine acceptance among haemodialysis patients: a French survey
por: Andrian, Titus, et al.
Publicado: (2021)

Chronic Kidney Disease-Associated Immune Dysfunctions: Impact of Protein-Bound Uremic Retention Solutes on Immune Cells
por: Espi, Maxime, et al.
Publicado: (2020)

CMPF: Class-switching minimized pathfinding in metabolic networks
por: Lim, Kevin, et al.
Publicado: (2012)

Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic Toxins
por: Florens, Nans, et al.
Publicado: (2016)

A low aromatic amino-acid diet improves renal function and prevent kidney fibrosis in mice with chronic kidney disease
por: Barba, Christophe, et al.
Publicado: (2021)

The Relationship between Renal Function and Plasma Concentration of the Cachectic Factor Zinc-Alpha2-Glycoprotein (ZAG) in Adult Patients with Chronic Kidney Disease
por: Pelletier, Caroline C., et al.
Publicado: (2014)

CMPF Does Not Associate with Impaired Glucose Metabolism in Individuals with Features of Metabolic Syndrome
por: Lankinen, Maria A., et al.
Publicado: (2015)

Expanded Haemodialysis as a Current Strategy to Remove Uremic Toxins
por: Ciceri, Paola, et al.
Publicado: (2021)

Uremic Toxins and Lipases in Haemodialysis: A Process of Repeated Metabolic Starvation
por: Stegmayr, Bernd
Publicado: (2014)

CMPF, a Metabolite Formed Upon Prescription Omega-3-Acid Ethyl Ester Supplementation, Prevents and Reverses Steatosis
por: Prentice, Kacey J., et al.
Publicado: (2017)

Kidney cachexia or protein‐energy wasting in chronic kidney disease: facts and numbers
por: Koppe, Laetitia, et al.
Publicado: (2019)

Crescentic glomerulonephritis with anti-PR3 ANCA associated with Bartonella henselae infective endocarditis
por: Andrian, Titus, et al.
Publicado: (2022)

Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients
por: Paats, Joosep, et al.
Publicado: (2020)

Proton-Pump Inhibitors and Serum Concentrations of Uremic Toxins in Patients with Chronic Kidney Disease
por: El Chamieh, Carolla, et al.
Publicado: (2023)

The association between TMAO, CMPF, and clinical outcomes in advanced chronic kidney disease: results from the European QUALity (EQUAL) Study
por: Dai, Lu, et al.
Publicado: (2022)

(2-Hydroxyethyl)(propyl)azanium 2-[(2-carboxyphenyl)disulfanyl]benzoate monohydrate
por: Broker, Grant A., et al.
Publicado: (2010)

Ketoacid Analogues Supplementation in Chronic Kidney Disease and Future Perspectives
por: Koppe, Laetitia, et al.
Publicado: (2019)

Usefulness and feasibility of measuring ionized calcium in haemodialysis patients
por: Jean, Guillaume, et al.
Publicado: (2015)

Uremic pruritus and serum brain-derived neurotrophic factor in diabetic and non-diabetic haemodialysis patients
por: Śnit, Mirosław, et al.
Publicado: (2019)

3-Carboxy-2-(2-cyclopropylamino-4-methylpyridinium-3-ylamino)pyridinium dinitrate dihydrate
por: Dong, Qiong, et al.
Publicado: (2011)

Source and Composition in Amino Acid of Dietary Proteins in the Primary Prevention and Treatment of CKD
por: Letourneau, Pierre, et al.
Publicado: (2020)

Ethane-1,2-diaminium bis(4-carboxy-2-propyl-1H-imidazole-5-carboxyate) monohydrate
por: Ying, Yi-Mei, et al.
Publicado: (2012)

Predictive role of altered leptin, adiponectin and 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid secretion in gestational diabetes mellitus
por: Florian, Andreea Roxana, et al.
Publicado: (2021)

Defining Uremic Arterial Functional Abnormalities in Patients Recently Started on Haemodialysis: Combined In Vivo and Ex Vivo Assessment
por: Abushufa, Adil M., et al.
Publicado: (2014)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

Intestinal Chelators, Sorbants, and Gut-Derived Uremic Toxins
por: Laville, Solène M., et al.
Publicado: (2021)

Evolution of renal function in patients with severe intestinal failure on home parenteral nutrition
por: Chalencon, Elodie, et al.
Publicado: (2020)

Comparison of Safety and Efficacy of Pregabalin versus Gabapentin for the treatment of Uremic Pruritus in Patients with Chronic Kidney Disease on Maintenance Haemodialysis
por: Ravindran, Ashima, et al.
Publicado: (2020)

4-Carboxypyridinium 3-carboxy-4-hydroxybenzenesulfonate
por: Wang, Zhong-long, et al.
Publicado: (2008)

Water-Soluble Vitamins and Trace Elements Losses during On-Line Hemodiafiltration
por: Bévier, Alban, et al.
Publicado: (2022)

Propylamine–borane
por: Gainsford, Graeme J., et al.
Publicado: (2009)

Diaquabis(5-carboxy-2-propyl-1H-imidazole-4-carboxylato-κ(2) N (3),O (4))nickel(II) tetrahydrate
por: Fan, Run-Zhen, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6k7pd9gv5r64k17kism1jtqi6u